Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1F | O60840 | 1/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.54 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.54 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.54 |
| ▸ | HRH1 | P35367 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.54 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.54 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14271356 | 0.88 | CACNA1F (0.50) | CACNA1FCHRM2CHRM1ADRA2BCHRM3 | |
| SCHEMBL21215304 | 0.83 | CACNA1F (0.47) | CACNA1FCHRM2CHRM1ADRA2BCHRM3 | |
| SCHEMBL271024 | 0.78 | — | — | |
| SCHEMBL11966006 | 0.78 | — | — | |
| SCHEMBL11966005 | 0.78 | — | — | |
| SCHEMBL19679360 | 0.77 | CACNA1F (0.42) | CACNA1FCHRM2CHRM1ADRA2BCHRM3 | |
| SCHEMBL18659330 | 0.75 | CACNA1F (0.41) | CACNA1FCHRM2CHRM1ADRA2BCHRM3 | |
| SCHEMBL24092097 | 0.75 | — | — | |
| SCHEMBL6200856 | 0.75 | — | — | |
| SCHEMBL24092090 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753429-B2 | Cobalt complex, method for manufacturing same, and method for manufacturing cobalt-containing thin film | TOSOH CORPORATION (JP) | 2023-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11753429-B2 | Cobalt complex, method for manufacturing same, and method for manufacturing cobalt-containing thin film | OR10J3, CNOT9, RNF10 | CACNA1F 1178/4885CHRM2 327/4885CHRM1 206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.